There are about 1.2 million Americans living with HIV and an estimated 50,000 new cases of HIV transmission each year. Sadly, most of these cases are among gay and bisexual men of color. That’s why now, more than ever, we need to increase awareness and uptake for Pre-Exposure Prophylaxis (PrEP), a new, highly effective tool to prevent the transmission of HIV.
PrEP involves an HIV-negative person taking the antiretroviral medication Truvada preventatively, once per day, to provide a high-level of protection against HIV. When used correctly, studies have shown that PrEP reduces the risk of getting HIV from sex by up to 99%. The medication Truvada is currently the only medication approved by the U.S. Food and Drug Administration (FDA) for PrEP.
If you decide that PrEP is right for you, you will need to talk to your primary care physician. Your doctor is the only person that can safely monitor you while you are on PrEP. PrEP is for HIV negative patients only, and routine HIV screening and blood work is required to remain on the medication.
Truvada works by preventing HIV from establishing in the body. If you are exposed to semen, vaginal fluids or blood from an HIV-positive person, then Truvada acts as a protective measure to halt transmission. For optimal protection, the pill should be taken daily.
All PrEP educational content and information on this website has been compiled from information consistent with current CDC guidelines for use of PrEP, Risk Evaluation and Mitigation Strategy (REMS) guidelines, and clinical trials of oral daily PrEP.
The information provided on this website is intended for your general knowledge only and is not a substitute for professional medical advice or treatment. Please consult your healthcare provider with any questions or concerns you may have regarding your health, including HIV prevention.
Supported by grant funding from Gilead Sciences, Inc. Gilead Sciences, Inc. has had no input into the development or content of these materials.